3.45
Polypid Ltd Aktie (PYPD) Neueste Nachrichten
Is PolyPid Ltd. forming a breakout patternDay Trade & Consistent Growth Stock Picks - thegnnews.com
Detecting price anomalies in PolyPid Ltd. with AIJuly 2025 WrapUp & Weekly Watchlist of Top Performers - Newser
Is PolyPid Ltd. a candidate for recovery playJuly 2025 Decliners & Verified Swing Trading Watchlists - Newser
Does PolyPid Ltd. qualify in momentum factor screeningJuly 2025 Outlook & Precise Trade Entry Recommendations - Newser
Pattern recognition hints at PolyPid Ltd. upside2025 Big Picture & Reliable Intraday Trade Plans - Newser
PolyPid Appoints New Chief Medical Officer Amid Strategic Advancements - MSN
PolyPid Reports Positive Phase 3 Results and Strengthens Leadership - MSN
PolyPid Releases Mid-2025 Financial Update - The Globe and Mail
Is PolyPid Ltd. affected by consumer sentimentJuly 2025 Chart Watch & Breakout Confirmation Trade Signals - classian.co.kr
PolyPid : Investor Presentation (3e767d) - MarketScreener
PolyPid Ltd. (NASDAQ:PYPD) Q2 2025 Earnings Call Transcript - Insider Monkey
Can PolyPid Ltd. navigate macro headwinds2025 Market Sentiment & Risk Controlled Daily Trade Plans - thegnnews.com
Will PolyPid Ltd. benefit from macro trendsWeekly Stock Recap & Expert Verified Stock Movement Alerts - Newser
Risk adjusted return profile for PolyPid Ltd. analyzedEarnings Performance Report & Free Community Supported Trade Ideas - Newser
PolyPid Reports Strong Phase 3 Results and Financial Update - TipRanks
Why PolyPid Ltd. stock attracts strong analyst attentionPortfolio Performance Report & AI Forecast Swing Trade Picks - Newser
PolyPid Q2 2025 Earnings Call Transcript - MarketBeat
PolyPid's Q2 2025 Earnings Call: Key Contradictions on CMC Readiness, GLP-1 Program, and Partnership Dynamics - AInvest
Transcript : PolyPid Ltd., Q2 2025 Earnings Call, Aug 13, 2025 - MarketScreener
908 Devices Inc. shares rise 8.11% intraday after PolyPid reported positive Phase 3 SHIELD II Trial Results. - AInvest
PolyPid Provides Corporate Update and Reports Second Quarter 2025 Financial Results - GlobeNewswire
PolyPid Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
PolyPid Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
How institutional ownership impacts PolyPid Ltd. stockDay Trade & Daily Profit Focused Screening - Newser
Developing predictive dashboards with PolyPid Ltd. dataJuly 2025 Sector Moves & Verified Swing Trading Watchlists - Newser
PolyPid's Surgical Innovation Shows Major Infection Prevention Success, Expands into Obesity Drug Market - Stock Titan
Live market analysis of PolyPid Ltd.July 2025 Price Swings & High Win Rate Trade Tips - Newser
Comparing PolyPid Ltd. in custom built stock radars2025 Trading Recap & Low Risk High Reward Ideas - Newser
What’s the recovery path for long term holders of PolyPid Ltd. [July 2025 Trends]High Accuracy Trade Alerts - Newser
Applying sector rotation models to PolyPid Ltd.Fundamental + Technical Combined Watchlist - Newser
PolyPid Ltd. Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer - Quiver Quantitative
PolyPid appoints Dr. Tweezer-Zaks as chief medical officer By Investing.com - Investing.com South Africa
PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer - GlobeNewswire
PolyPid Strengthens Leadership: Board Director Takes CMO Role Following Breakthrough Phase 3 Results - Stock Titan
Combining machine learning predictions for PolyPid Ltd.Pre-Market Stock Movement Summary and Review - Newser
PolyPid Ltd. stock volume spike explainedDeep Stock Performance and Volatility Analysis - Newser
PolyPid (PYPD) to Release Quarterly Earnings on Wednesday - Defense World
What makes PolyPid Ltd. stock price move sharplyQuarterly Investment Outlook and Key Summary - Newser
Sector ETF performance correlation with PolyPid Ltd.Long Term Stock Growth Plan Suggestions - Newser
Custom watchlist performance reports with PolyPid Ltd.Swing Entry Risk Mitigation with Chart Analysis - Newser
Running Global Clinical Trials? PolyPid Shares Operational And Regulatory Insights - Clinical Leader
Sector ETF performance correlation with PolyPid Ltd. [Portfolio Value Summary]Weekly Watchlist of Top Performers - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):